Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Breast Fibroadenoma Targeted Tissue With HIFU

NCT: NCT03044054 · COMPLETED

NCT IDNCT03044054
StatusCOMPLETED
Start Date2017-01
Completion2026-04

Brief Summary

This study evaluates the efficacy and the safety of the HIFU for the treatment of breast fibroadenoma.

Frequently Asked Questions

What is Treatment of Breast Fibroadenoma Targeted Tissue With HIFU?

Treatment of Breast Fibroadenoma Targeted Tissue With HIFU is a clinical trial registered under NCT03044054. Current status: COMPLETED.

What is the status of NCT03044054?

The current status of NCT03044054 (Treatment of Breast Fibroadenoma Targeted Tissue With HIFU) is: COMPLETED.

When did Treatment of Breast Fibroadenoma Targeted Tissue With HIFU start?

Treatment of Breast Fibroadenoma Targeted Tissue With HIFU started on 2017-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑